These cases are selected based on their likely precedential value, importance to drug and device manufacturers, and inherent (and subjective) merit. This seminar presents these decisions, and what they mean about the direction of the law in this space, in a more in-depth and informative setting.

Speakers:

• James M. Beck, Senior Life Sciences Policy Analyst, Philadelphia
• Steven J. Boranian, Partner, San Francisco
• Stephen J. McConnell, Partner, Philadelphia
• Lisa M. Baird, Partner, Miami

Thursday, January 25, 2024

• 12:00 p.m. - 1:30 p.m. ET
• 11:00 a.m. - 12:30 p.m. CT
• 10:00 a.m. - 11:30 a.m. MT
• 9:00 p.m. - 10:30 a.m. PT

CLE Information:
This program is presumptively approved for 1.5 CLE credit in California, Connecticut, Illinois, New Jersey, New York, Pennsylvania, Texas and West Virginia. Applications for CLE credit will be filed in Delaware, Florida, Ohio, and Virginia. Attendees who are licensed in other jurisdictions will receive a uniform certificate of attendance but Reed Smith only provides credit for the states listed. Please allow 4-6 weeks after the program to receive a certificate of attendance.

FOR ON-DEMAND VIEWERS:
In order to receive CLE credit, you will need to notify Learning & Development CLE Attendance once you have viewed the program on-demand.

**Please note - CLE credit for on-demand viewing is only available in California, Connecticut, Illinois, New Jersey, New York, Pennsylvania, Texas and West Virginia. Credit availability expires two years from the date of the live program.